Logo for University of Iowa Health Care This logo represents the University of Iowa Health Care

Dean's List: New Funding Awards

Notable & novel scientific awards to celebrate. 

2020: January & February
2019: JanuaryFebruaryMarchApril, May, June, July August, September, October, November & December
2018: July, August, September, October, November & December


New Federal Awards

Vladimir Badovinac  •  Pathology
Cellular and molecular mechanisms controlling sepsis-induced immunoparalyses state
NIH R35  •  5 years

Sarah Beattie  •  Pediatrics
Development of a high throughput screening-compatible assay for filamentous fungi
NIH F32  •  3 years

Gail Bishop  •  Microbiology & Immunology
Loss of TRAF3 in aging B lymphocytes
NIH R21  •  2 years

Morgan Bobb  •  Emergency Medicine
Factors in Pediatric Sepesis Mortality
NIH F30  •  3 years

Christine Cho  •  Internal Medicine
Study of Neisseria gonorrhoeae adaptability
NIH K08  •  5 years

Prajwal Gurung  •  Internal Medicine
Elucidating CD47-SHP1 biology to understand autoinflammatory disorders
NIH R21  •  2 years

Damian Krysan  •  Pediatrics
Carbon dioxide tolerance in Cryptococcus pathogenesis
NIH R01  •  5 years

Scott Moye-Rowley  •  Molecular Physiology & Biophysics
Identification of virulence determinants under the transcriptional control of AtrR in Aspergillus fumigatus
NIH R21  •  2 years

Alicia Ortiz  •  Biochemistry
Investigating E-cadherin mechanotransduction
NIH F31  •  2 years

Matthew Potthoff  •  Neuroscience & Pharmacology
Endocrine regulation of alcohol intake
NIH R01  •  5 years

Richard Roller  •  Microbiology & Immunology
Mechanism and regulation of protein kinase functions in HSV nuclear egress
NIH R21  •  2 years

Gen Shinozaki  •  Psychiatry
Identification of epigenetics correlates between brain and peripheral tissues
NIH R01  •  5 years

Yatin Vyas  •  Pediatrics
Mechanisms of R loop-mediated genome instability in Wiskott-Aldrich syndrome
NIH R01  •  5 years

Li Wu  •  Microbiology & Immunology
SAMHD1-mediated regulation of HIV-1 innate immunity and viral gene expression
NIH R01  •  4 years

Other Awards

Bryan Allen  •  Radiation Oncology
Effects of GC4419 on the Incidence and Severity of Esophagitis in Subjects Receiving Chemoradiotherapy for Lung Cancer
Galera Therapeutics, Inc.

Rohan Garje  •  Internal Medicine
Avelumab in Combination with Bempegaldesleukin (NKTR-214) with or without Talazoparib or Enzalutamde in Participants with Locally Advanced or Metastatic Solid Tumors
Pfizer, Inc.

Donna Hammond  •  Anesthesia
Alleviation of Paclitaxel-Induced Peripheral Neuropathies in Cancer Survivors
V Foundation for Cancer Research

Pashtoon Kasi  •  Internal Medicine
mFOLFOX6 + trastuzumab + avelumab in first-line, metastatic, HER2-amplified gastric and esophageal adenocarcinomas
Hoosier Cancer Research Network, Inc.

Douglas Laux  •  Internal Medicine
ADU-S100 & Pembolizumab in Adults with Head/Neck Cancer
Aduro BioTech, Inc.

Michael Shy  •  Neurology
A Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth 4J
Neurogene, Inc

Michael Tansey  •  Pediatrics
Diabetes autoimmunity withdrawn in new onset and in established patients (SUNRISE)
Tolerion, Inc. 


Competitive Renewals

John Harty  •  Microbiology and Immunology
Vladmir Badovinac  •  Pathology
Memory CD8 T cell localization and protection from influenza
NIH R01  •  5 years

Richard Smith  •  Otolaryngology
Non-Syndromic Hearing Loss: Collaborative Study
NIH R01  •  5 years

New Federal Awards

Aaron Boes  •  Pediatrics
Predicting Cognitive Outcomes from Stroke Based on Lesion Location
NIH R01  •  5 years

Mark Niciu  •  Psychiatry
Ketamine's Enhanced Antidepressant Efficacy in Subjects with a Family History of an Alcohol Use Disorder
NIH R00  •  3 years

Munir Tanas  •  Pathology
Epigenetic modulation of the TAZ-CAMTA1 transcriptional program by the Ada2a-containing histone acetyltransferase complex
NIH R01  •  5 years

Sam Young  •  Anatomy and Cell Biology
Presynaptic regulation of neurotransmitter release in mammlian neuronal circuits
NIH R01  •  5 years

Chen Zhao  •  Pathology
Heat Shock Transcription Factor 1 Specifically Regulates AML Stem Cell Self-Renewal
NIH R01  •  5 years

Eliot Zhu  •  Anatomy and Cell Biology
Rivers of MAPK-redundant resistance to BRAF inhibition n melanoma
NIH F30  •  5 years

Rebecca Dodd  •  Internal Medicine
Exploiting Epigenetic Pathways in Soft Tissue Sarcomas
American Cancer Society

Muhammad Furqan  •  Internal Medicine
Durvalumab Following Stereotactic Body Radiation Therapy or the Treatment of Patients with Stage I/II Non-small Cell Lung Cancer
AstraZeneca LP

Carlos Vigil Gonzales  •  Internal Medicine
Alvocidib When Administered in Sequence After Decitabine in Patients with MDS
Tolero Pharmaceuticals, Inc

Yogesh Jethava  •  Internal Medicine
SEA-BCMA in patients with relapsed or refractory multiple myeloma
Seattle Genetics, Inc.

Mohammad Milhem  •  Internal Medicine
IMCnyeso and LAGE-1A-specific Soluble T Cell Receptor and Anti-CD3 Bispecific Molecule as a Single Agent in HLA-A*0201 Positive Patients
Immunoscore Limited

Carla Nester  •  Pediatrics
The long-term efficacy, safety and tolerability of LNP023 in subjects with C3 glomerulopathy
Novartis Pharmaceutical Corp.

Yousef Zakharia  •  Internal Medicine
Neoadjuvant/Adjuvant Nivolumab Plus NKTR-214, Versus Nivolumab Alone Versus Standard of Care in Participants with Muscle-Invasive Bladder Cancer Who Are Cisplatin Ineligible
Bristol-Myers Squibb Co.


New Federal Awards

Brian Gehlbach  •  Internal Medicine
George Richerson  •  Neurology
The role of central CO2 chemosensitivity in postictal respiratory depression and SUDEP
NIH R01  •  5 years

Patricia Winokur  •  Internal Medicine
Phase II Therapeutic Trial for Trichuris trichura
NIH VTEU contract  •  2 years

Other Awards

Yehudith Assouline-Dayan  •   Internal Medicine
Olorinab in Subjects with Irritable Bowel Syndrome Experiencing Abdominal Pain
Arena Pharmaceuticals, Inc

David Bender  •  Obstetrics and Gynecology

John Bernat  •  Pediatrics
Intrathecal SHP611 in Subjects with Late Infantile Metachromatic Leukodystrophy
Shire Human Genetic Therapies, Inc

Muhammad Furqan  •  Internal Medicine
Pemigatinib with Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignances
Incyte Corporation

Yogesh Jethava  •  Internal Medicine
PF-06863135, a B-Cell Maturation Antigen (BCMA) - CD3 Bispecific Antibody in Patients with Relapsed/Refractory Advanced Multiple Myeloma
Pfizer, Inc

Mohammad Milhem  •  Internal Medicine
RP1 as a Single Agent and in Combination with PD1 Blockade in Patients with Solid Tumors
Replimune, Ltd

Yousef Zakharia  •  Internal Medicine
Ibrutinib Combination Therapy in Selected Advanced Gastrointestical and Genitourinary Tumors
Pharmacyclics LLC


Competitive Renewals

Peg Nopoulos  •  Psychiatry
Growth and development of Striatal-Cerebelum circuitry in subjects at risk for Huntington's Disease
NIH U01  •  5 years

Karl Kreder  •  Urology
Catherine Bradley  •  Obstetrics and Gynecology

University of Iowa LURN Research Site
NIH U01  •  5 years

New Federal Awards

John Engelhardt  •  Anatomy and Cell Biology
National Ferret Resource & Research Center on Lung Disease
NIH Contract  •  1 year

Melissa Fath  •   Radiation Oncology
Repurposing redox active agents for exploiting differences in cancer cell metabolism for improving cancer therapy
NIH R50  •  5 years

Yuya Hagiwara  •  Internal Medicine
Program Development and Educational Research in Geriatrics and Palliative Care
HRSA K01  •  4 years

Collin Heer  •  Radiation Oncology
Selective targeting of tumor cell redox metabolism and DNA damage responses to enhance cancer therapy
NIH F99  •  2 years

Marco Hefti  •  Pathology
Novel tau-based diagnostics for neonatal hypoxic-ischemic injury
NIH K23  •  5 years

Fang Lin  •  Anatomy and Cell Biology
The role of Glypican 4 in gut endoderm morphogenesis
NIH R56  •  1 year

John Maddox  •  Molecular Physiology and Biophysics
Voltage-gated calcium channels in the development of photoreceptor synapses
NIH F32  •  2 years

Bradley McDowell  •  Internal Medicine
Building a patient-centered cancer data mart in rural state
NIH R50  •  5 years

Philip Polgreen  •  Internal Medicine
Aaron Miller  •  Epidemiology

Incidence, risk and harms associated with diagnostic delays for infectious diseases
AHRQ R01  •  3 years

Julien Sebag  •  Molecular Physiology and Biophysics
Identification of the Prokineticin 1 Receptor, a novel target for the treatment of obesity
NIH R03  •  1 year

Kathleen Sluka  •  Physical Therapy and Rehabilitation Science
Fibromyalgia TENS in Physical Therapy Study
NIH UG3  •  1 year

Other Awards

Richard Ahrens  •  Pediatrics
Study to Compare Creon Drug Products in Subjects with EPI due to Cystic Fibrosis
AbbVie, Inc

William Coryell  •  Psychiatry
Cariprazine as an adjunct to antidepressants in the treatment of patients with major depressive disorder
Allergan Sales

Mohammad Milhem  •  Internal Medicine
RO6874271 in Combination with Pembrolizumab in Participants with Melanoma
Genenthech, Inc.

Michael Shy  •  Neurology
A083-04 Clinical Trial
Acceleron Pharma, Inc

Lucy Wibbenmeyer  •  Surgery
Regenerative Epidemal Suspension Compared to Conventional Care for Healing of Donor Sites in Infants, Children and Adolescents
Avita Medical Americas, LLC

Yousef Zakharia  •  Internal Medicine
KHK2455 in Combination with Avelumab in Subjects with Locally Advanced or Metastatic Urothelial Carcinoma
Kyowa Kirin Pharmaceutical Develoment, Inc


Competitive Renewals

Pamela Geyer  •  Biochemistry
The Role of LEM Domain Proteins in Nuclear Function
NIH R01  •  4 years

Karl Kreder  •  Urology
Urology Chornic Pelvic Pain Longitudinal Symptom Patterns Study
NIH U01  •  3 years

Michael Shy  •  Neurology
The Inherited Neuropathy Consortium
NIH U54  •  5 years

New Federal Awards

Ryan Boudreau  •  Internal Medicine
The genomic interface of microRNA regulation and heart failure
NIH R01  •  4 years

Joseph Glykys  •  Pediatrics
Osmotic Therapy for Seizures in Pediatric Traumatic Brain Injury
NIH K08  •  1 year

Amy Lee  •  Molecular Physiology and Biophysics
Illuminating the functions of CACNA2D4 in the brain
NIH R03  •  1 year

W. Scott Moye-Rowley  •  Molecular Physiology and Biophysics
Analysis of transcription factors determining azole resistance of Aspergillus fumigatus
NIH R01  •  5 years

Julien Sebag  •  Molecular Physiology and Biophysics
Identification of the central localization and regulation of the Prokineticin 1 Receptor, a novel target for the treatment of obesity
NIH R03  •  1 year

Michael Shy  •  Neurology
Clinical Trial Readiness for Rare Diseases, Disorders and Syndromes
NIH R21  •  2 years

Kathleen Sluka & Laura Frey Law  •  Physical Therapy and Rehabilitation Science
Clinical Coordinating Center for the Acute to Chronic Pain Signatures Program
NIH U24  •  4 years

Other Awards

Philip Horwitz  •  Internal Medicine
Boston Scientific Corporation

Ali Jabbari  •  Dermatology
PF-06651600 in adult and adolescent alopecia araeata subjects
Pfizer, Inc

Douglas Laux  •  Internal Medicine
Pembrolizumab as adjuvant therapy following surgery and radiation in subjects with cutaneous squamous cell carcinoma
Merck & Company, Inc

Delwyn Miller  •  Psychiatry
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease
University of Southern California

Arvind Murali  •  Internal Medicine
ARO-AAT in Patients with Alpha-1 Antitrypsin Deficiency
Arrowhead Pharmaceuticals, Inc.

Warren Schmidt  •  Internal Medicine
Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcohollic Steatohepatitis
Allergan Sales, LLC

JULY 2019

Competitive Renewals

Steven Lentz  •  Internal Medicine
Program in Hematology: Molecular & Cell Biology Blood Cells
NIH T32  •  5 years

New Federal Awards

Ted Abel  •  Molecular Physiology & Biophysics
Mechanistic tudies on the impact of sleep deprivation on gene regulation
NIH R01  •  5 years

Gail Bishop  •  Microbiology & Immunology
Tumor-Initiating Cell as a Novel Therapeutic Target in Myeloma
DoD CDMRP  •  4 years

Aaron Boes  •  Pediatrics
Investigating the Effects of Transcranial Magnetic Stimulation with Intracranial EEG in Humans
NIH R21  •  2 years

Daniel Infield  •  Molecular Physiology & Biophysics
Chemical Biology of CFTR Regulation
NIH F32  •  2 years

Enrique Leira  •  Neurology
University of Iowa Stroke Preclinical Assessment Center for Neuroprotection in Stroke
NIH U01  •  3 years

Jonathan Nizar  •  Internal Medicine
Contribution of Renal Tubule Insulin Receptor on Proximal Tubule Sodium Transport & Hypertension in Metabolic Syndrome
NIH K08  •  3 years

Richard Smith  •  Otolaryngology - Head and Neck Surgery
Autosomal Dominant Non-Syndromic Hearing Loss - Its Genetic Diagnosis and Treatment
NIH R01  •  5 years

Amy Whillock  •  Microbiology & Immunology
Regulation of the B cell receptor and B cell homeostasis by tumor necrosis factor receptor associated factor 3
DoD CDMRP  •  2 years

Samuel Young  •  Anatomy and Cell Biology
Development of Helper Dependent Adenoviral Vectors for Inner Ear Gene Therapy Approaches
NIH R21  •  2 years

Fenghuang Zhan  •  Internal Medicine
Tumor-Initiating Cell as a Novel Therapeutic Target in Myeloma
DoD CDMRP  •  4 years

Other Awards

Charles Brenner  •  Biochemistry
Testing NAD Precursors as Galactagogues
Bill & Melinda Gates Foundation

Charles Brenner  •  Biochemistry
Evaluating the Oral Bioavailability of NAD Boosters
ChromaDex, Inc.

Rob Cornell  •  Anatomy & Cell Biology
Genomic and Functional Analysis of IRF6 Target Genes in Orofacial Cleft Pathogenesis
Massachusetts General Hospital

Muhammad Furqan  •  Internal Medicine
Durvalumab in Combination With Novel Oncology Therapies, in First-Line Stage IV Non-Small Cell Lung Cancer
AstraZeneca Pharmaceuticals LP

Laurie Gutmann  •  Neurology
ERX-963 in Adults with Myotonic Dystrophy Type 1
Expansion Therapeutics, Inc.

Eric Hoffman  •  Radiology
Precision Biologic Interventions for Severe Exacerbation Prone Asthma (PrecISE)
Washington University in St. Louis

Brian Link  •  Internal Medicine
A Prospective Disease Registry of Patients with Mantle Cell Lymphoma Treated with Novel Agents
AstraZeneca Pharmaceuticals LP

Kathy Mathews  •  Pediatrics
Patients with Duchenne Muscular Dystrophy Enrolled in Clinical Trials Evaluating Casimersen or Golodirsen
Sarepta Therapeutics

David Stoltz  •  Internal Medicine
Iowa Cystic Fibrosis Foundation Research & Development Program
Cystic Fibrosis Foundation

Carlos Enrique Vigil Gonzales  •  Internal Medicine
APR-246 in Combo with Azacitidine vs Azacitidine Alone for Treatment of TP53 Mutant Myelodysplastic Syndromes
Aprea Therapeutics

Yousef Zakharia  •  Internal Medicine
Cabozantinib and Pembrolizumab as a Front Line Therapy for Advanced Melanoma
Exelixis, Inc.

JUNE 2019

Competitive Renewals

Christopher Ahern  •  Molecular Physiology & Biophysics
Chemical Biology of Voltage-Gated Cation Channels
NIH R01  •  4 years

Lee-Ann Allen  •  Internal Medicine
John Harty  •  Microbiology & Immunology

Interdisciplinary Immunology Postdoctoral Training Program
NIH T32  •  5 years

New Federal Awards

Ruth Chimenti  •  Physical Therapy & Rehabilitation Science
Mechanism-based treatment approach to chronic tendinopathy pain
NIH R00  •  3 years

Josalyn Cho  •  Internal Medicine
Tim3 is a novel regulator of dendritic cell-T cell interactions in influenza
NIH K08  •  1 year

Catherine Marcinkiewcz  •  Pharmacology
The role of serotonin in signaling in the nucleus accumbens in excessive alcohol drinking
NIH R00  •  3 years

Yusuf Menda & Michael Schultz  •  Radiology
Alpha-Particle Emitter Peptide Receptor Targeted Radionuclide Therapy for Neuroendocrine Tumors
NIH R01  •  5 years

Val Sheffield  •  Pediatrics
Novel Genome Editing for the Treatment of Glaucoma
NIH R01  •  5  years

Yuriy Usachev  •  Pharmacology
The Role of the Complement System in Spinal Mechanisms of Chronic Pain
NIH R01  •  5 years

Other Awards

Allan Andersen  •  Psychiatry
An integrated epigenetic ELISA saliva kit for detecting & quantifying both tobacco and nicotine use
Behavioral Diagnostics, LLC

Steven Bailin  •  Internal Medicine
Boston Scientific Corporation

Camille Dunn-Johnson  •  Otolaryngology
Iowa Cochlear Implant Clinical Research Center Study of SSD using MED-EL Cochlear Implants
MED-EL Corporation

Muhammad Furqan  •  Internal Medicine
SC-011 as a Single-Agent and in Combination with ABBV-181 in Subjects with Relapsed or Refractory Small Cell Lung Cancer
AbbVie, Inc

Mohammed Milhem  •  Internal Medicine
Pembrolizumab versus Placebo in Resected Highrisk Stage II Melanoma
Merck Sharp & Dohme Company

Michael Shy  •  Neurology
ALN-TTRSC02 in Patients with hATTR Amyloidosis
Alnylam Pharmaceuticals, Inc.

Jack Stapleton  •  Internal Medicine
POX-MWA-031 Clinical Trial
Bavarian Nordic

Carlos Enrique Vigil Gonzales  •  Internal Medicine
Venetoclax & AMG 176 in Patients with Relapsed/Refractory
AbbVie, Inc

MAY 2019

New Federal Awards

Nazan Aksan  •  Neurology
Evaluating the disease-modifying potential of a sleep intervention for Alzheimer's Diseases outcome
NIH R01  •  5 years

Vladimir Badovinac  •  Pathology
Differentiation of pathogen-specific memory CD8 T cell responses
NIH R21  •  2 years

Craig Ellermeier  •  Microbiology & Immunology
Extra-Cytoplasmic Function Sigma Factor Senses and Responds to Beta-Lactam Stress in Gram-Positive Bacteria
NIH R21  •  2 years

Eric Hoffman & Stanley Kruger  •  Radiology
Hyperpolarized Xe-129 MRI for Functional Lung Phenotyping
NIH S10  •  1 year

Balaji Manicassamy  •  Microbiology & Immunology
Modulation of Influenza Virus Replication and Fitness by Adenosine Deaminases
NIH R01  •  2 years

Barry London & Kaikobad Irani •  Internal Medicine
Charles Brenner  •  Biochemistry

Evaluating NAD Supplementation as a Novel Treatment for Arrhythmias
NIH R01  •  4 years

Peter Snyder  •  Internal Medicine
9th Annual International Conference of Aldosterones and ENaC
NIH R13  •  1 years

Shujie Yang  •  Obstetrics & Gynecology
Restoring Progesting Sensitivity in Endometrial Cancer
NIH R01  •  5 years

Other Awards

David Bender  •  Obstetrics & Gynecology
2019 NRG Oncology Member Institution Clinical Trial
NRG Oncology Foundation, Inc.

Varun Monga  •  Internal Medicine
DCC-2618 vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumors after Treatment with Imatinib
Deciphera Pharmaceauticals, LLC

Stephen Russell  •  Ophthalmology & Visual Sciences
ORA-ProQR QR-110-002 LCA Extension Study
ProQR Therapeutics B.V.

APRIL 2019

Competitive Renewals

Robert Mullins & Budd Tucker  •  Opthalmology & Visual Sciences
Choriocapillaris Protection and Replacement in AMD
NIH R01  •  4 years

Michael Shy  •  Neurology
The Inherited Neuropathy Consortium
Charcot-Marie-Tooth Association

New Federal Awards

Josalyn Cho  •  Internal Medicine
Airway Dendritic Cells in the Allergic Asthma Phenotype
NIH UH2  •  2 years

Kathleen Sluka  •  Physcial Therapy & Rehabilitation Sciences
Role of macrophages in activity-induced pan and analgesia
NIH R01  •  5 years

Marin Schweizer  •  Internal Medicine
Povidone-iodine to Stop Access-related Infections Transmission of Staphylococcus aureus (PAINTS)
AHRQ R01  •  5 years

Other Awards

Carlos Vigil Gonzalez  •  Internal Medicine
CPI-613 in Combination with High Dose Cytarabine and Mitoxantrone (CHAM) Compared to High Dose Cytarabine and Mitoxantrone (HAM) in Older Patients
Rafael Pharmaceuticals, Inc.

Matthew Howard  •  Neurosurgery
Neuronal Substrates of Hemodynamic Signals in the Prefrontal Cortex
California Institute of Technology

Dominique Limoli  •  Microbiology & Immunology
Michael Welsh  •  Internal Medicine

Modulating interspecies interactions in cystic fibrosis respiratory disease
Cystic Fibrosis Foundation

Michael Tomasson  •  Internal Medicine
Idasanutlin in Combination with Cytarabine and Daunorubicin in Patients Newly Diagnosed with AML and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission
Hoffmann-La Roche, Inc.

Yousef Zakharia  •  Internal Medicine
A Phase I Study of ASP1951 in Subjects with Advanced Solid Tumors
Astellas Pharma Global Development


MARCH 2019

Competitive Renewals

Robert Cornell  •  Anatomy & Cell Biology
Dissecting the transcriptional network governing differentiation of periderm
NIH R01  •  5 years

Chou-Long Huang  •  Internal Medicine
Klotho and Chronic Kidney Disease
NIH R01  •  5 years

Andrew Russo  •  Molecular Physiology & Biophysics
Perivascular mechanisms of CGRP-induced migraine symptoms
NIH R01  •  5 years

New Federal Awards

Alicia Gerke  •  Internal Medicine
Biomarkers for Severity, Therapy, and Disparity in Sarcoidosis: Discovery to Delivery
NIH R13  •  1 year

David Hasan  •  Neurosurgery
15-PGDH as a better therapeutic taret than aspirin in decreasing risk of intracranial aneurysm rupture in men and women equally
NIH R01  •  5 years

Elizabeth Newell  •  Pediatrics
Astrocyte-specific IL-1RL signaling effects following traumatic brain injury
NIH K08  •  5 years

Kalpaj Parekh  •  Surgery
Pathogenesis of Airway Stem Cell Abnormalities on Obliterative Bronchiolitis
NIH R01  •  5 years

Maria Spies  •  Biochemistry
Assembly and Dynamics of Molecular Machines in Genome Maintenance
NIH R35  •  5 years

Maria Spies  •  Biochemistry
Modulating Cancer Genetics for Immune Regulation and Breast Cancer Therapy
US Department of Defense, CDMRP  •  3 years

Maria Spies  •  Biochemistry
The role of human RAD52 protein in genome stability
NIH R01  •  5 years

Other Awards

Steven Polyak  •  Internal Medicine
The Efficacy and Safety of Upadacitinab (ABT-494) in Subjects with Moderately to Severely Active Ulcerative Colitis
AbbVie, Inc.

Katie Larson Ode  •  Pediatrics
EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis
Cystic Fibrosis Foundation

Michael Graham  •  Radiology
ImaginAb Clinical Trial
ImaginAb, Inc.

Randy Loftus  •  Anesthesia
The Attenuation of Intraoperative S. aureus Transmission and SSIs via Use of Indigo-Clean
Kenall Manufacturing

Christopher Nancy  •  Neurology
NeuroNext Clinical Trial - The TopCSPN Study/Topiramate as a Disease Modifying Therapy for CSPN
Massachusetts General Hospital

Helena Kenny  •  Internal Medicine
OPA1 KO Causes Cardiac Dysfunction, ER Stress and Heart Failure
MyoKardia, Inc

Stefan Strack  •  Pharmacology
Generation and characterization of mouse models of Jordan's Syndrome
Regents of the University of California, Davis

Loreen Herwaldt  •  Internal Medicine
Epicenters for the Prevention of Healthcare-Associated Infections (HAIs); Cycle II Multicenter Program Studies
University of Illinois at Chicago



Competitive Renewals

Kim Leslie  •  Obstetrics & Gynecology
Targeted Therapy for Endometrial Cancer
NIH R01  •  5 years

New Federal Awards

Corinne Griguer  •  Radiation Research Lab
Paracrine Signaling in Glioma: Bioenergetics Heterogeneity and Chemoresistance
NIH R21  •  1 year

Balaji Manicassamy  •  Microbiology & Immunology
Endothelial Cell Tropism in the Pathogenesis and Host Response against Influenza Viruses
NIH R01  •  4 years

Other Awards

Nicholas Mohr  •  Emergency Medicine
Evaluating the Role of Telemedicine in Improving Rural Emergency Department Sepsis Care

Mohammed Milhem  •  Internal Medicine
AST-008-102: A Phase 1b/2 Study of AST-008 Combined with Pembrolizumab in Patients with Advanced Solid Tumors
Exicure, Inc.

Mohammed Milhem  •  Internal Medicine
A Phase 1b/2 Study of FT-2102 in Patients with Advanced Solid Tumors and Gliomas with an IDH1 Mutation
Format Therapeutics, Inc.

Mohammed Milhem  •  Internal Medicine
A Phase 1/2, Open-label, Multicenter, Dose Escalation and Dose Expansion Study of NKTR-262 in Combination with NKTR-214 plus Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumor Malignancies
Nektar Therapeutics

Michael O'Donnell  •  Urology
A Multicenter, Single-Arm Study Evaluating the Efficacy of Synergo Radiofrequency-Induced Thermochemotherapy Effect (RITE) with Mitomycin C (Synergo RITE + MMC) in CIS Non-Muscle Invasive Bladder Cancer (NMIBC)
Medical Enterprises Europe B.V.

Yehudith Assouline-Dayan  •  Internal Medicine
A Phase 3, Randomized, 3-Part Study to Investigate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients with Eosinophilic Esophagitis
Regeneron Pharmaceuticals, Inc.



Competitive Renewals

Kelly Falls  •  Radiation Research Laboratory
Targeting lung and breast cancer cell oxidative metabolism with D-penicillamine and disulfiram
NIH F30  •  2 years

George Weiner  •  Holden Comprehensive Cancer Center
Institutional Research Grant
American Cancer Society

New Federal Awards

Ryan Boudreau  •  Internal Medicine
Regulation and role of the cardiac sodium channel Nav1.5 in heart failure
NIH R01  •  5 years

John Fingert  •  Ophthalmology & Visual Sciences
Michael Anderson  •  Molecular Physiology & Biophysics

CRISPR/CAs9 approaches to model exfoliation syndrome
NIH R21  •  2 years

Dao-Fu Dai  •  Pathology
The role of energy sensor signaling in mitochondrial cardiomyopathy
NIH K08  •  5 years

Corinne Griguer  •  Radiation Research Laboratory
Cytochrome C Oxidase: Biomarker in Newly Diagnosed Glioblastomas Multiforme
NIH U01  •  2 years

Denise Hodgson-Zingman  •  Internal Medicine
A New Pacing Approach for Cardioprotection and Repair In Heart Failure
NIH R21  •  2 years

Alejandro Pezzulo  •  Internal Medicine
Heat-shock protein 90 modulates goblet cell metaplasma in human airway epithelia
NIH K01  •  5 years

Mark Santillan  •  Obstetrics & Gynecology
Vasopressin and Preeclampsia: Early Mechanisms for Prevention
NIH R01  •  5 years

Budd Tucker  •  Ophthalmology & Visual Sciences
Robert Mullins •  Ophthalmology & Visual Sciences

Molecular Basis of Complement Defense in Choroidal Endothelial Cells
NIH R21  •  2 years

Other Awards

Michael Tansey  •  Pediatrics
Evolucumab for Low Density Lipoprotein-Cholesterol (LDL-C) Reduction, as Add-On to Diet and Lipid-Lowering Therapy, in Pediatric Subjects 10 to 17 Years of Age with Heterozygous Familial Hypercholesterolemia (HeFH)
Amgen, Inc.

Eric Taylor  •  Biochemistry
Metabolomic Mechanisms of Action in the Mitochondrial Pyruvate Carrier Modulator MSDC-0602K
Cirius Therapeutics, Inc.

Yousef Zakharia  •  Internal Medicine
Proof of concept for lenvatinib and reverolimus prior to cytoreductive nephrectomy in eligible patients with locally advanced metastatic renal cell carcinoma (RCC)
Eisai, Inc.

Yousef Zakharia  •  Internal Medicine
Combination of Axitinib and Selenium in the Chemical Composition of Selenomethione (SLM) for adult patients with advanced metastatic clear cell renal cell carcinoma (CCRCC)
Pfizer, Inc.

Rohan Garje  •  Internal Medicine
Study of 177Lu-PSMA-617 in the Treatment of Patients with Progressive PSMA-Positive Metastatic Castration-Resistance Prostate Cancer
Endocyte, Inc.

John Bernat  •  Pediatrics
Long-Term Safety and Efficacy of Pegunigalsidase Alfa (PRX-102) 2 mg/kg Administered by Intravenous Infusion Every 4 Weeks in Patients with Fabry Disease
Protalix Biotherapeutics

John Engelhardt  •  Anatomy & Cell Biology
Statement of Work
Talee Bio, Inc.

Andrea Swenson  •  Neurology
Arimoclomol in Amyotrophic Lateral Sclerosis
Worldwide Clinical Trials, Inc.



Competitive Renewals

John Harty  •  Microbiology & Immunology
T resident memory in the lung
NIH R01  •  5 years

Denise Martinez  •  Medicine Administration
Summer Health Professions Education Program
Robert Wood Johnson Foundation

New Federal Awards

Anil Chauhan  •  Internal Medicine
Novel Therapeutic Intervention to Treat Ischemic Stroke
NIH R01  •  5 years

James Davis  •  Pediatrics
Fungal and Host Factors in Initiation of Cryptococcal Persistence
NIH K08  •  4 years

Krystal Parker  •  Psychiatry
Cerebellar circuits, timing, and cognition
NIH R01  •  5 years

David Weiss  •  Microbiology & Immunology
REU Site: Microbiology at The University of Iowa
NSF  •  3 years

Other Awards

Matthew Howard  •  Neurosurgery
Casual mapping of emotion networks with concurrent electrical stimulation of fMRI
California Institute of Technology

C. Michael Knudson  •  Tissue Procurement Core
Leidos, Inc.

Richard Smith & Carla Nester  •  Otolaryngology
C3 Glomerulopathy - A Longitudinal and Disovery Study
Novartis Corporation

Doug Laux  •  Internal Medicine
A randomized, open-label, multicenter, phase 1b/2 trial evaluating the safety and efficacy of intratumorally-administered ilixadencel in combination with CPI
Immunicum AB

John Bernat  •  Pediatrics
A Randomized, Double blind, Active Control Study of the Safety and Efficacy of PRX-102 to Agalside Beta on Renal Function in patients with Fabry Disease previously treated with Agalsidase Beta
Protalix Biotherapeutics



New Federal Awards

Ted Abel  •  Physiology & Biophysics
Molecular, Cellular and Circuit Effects of Sleep Deprivation on Hippocampus Function
NIH R01  •  5 years

Donna Hammond  •  Anesthesia
Nicotinamide Riboside for Relief of Taxane-Induced Sensory Neuropathy
NIH R21  •  2 years

Alison Lynch  •  Psychiatry
Collaborative Medication Assisted Treatment in Iowa 
SAMHSA H79  •  3 years

Frida Teran  •  Neurology
A novel dietary therapy for epilepsy: potential mechanisms of action
NIH F31  •  4 years

Aliye Uc  •  Pediatrics
Non-Pharmacological Pain Intervention for Pediatric Chronic Pancreatitis
NIH R01  •  5 years

Jason Wilken  •  Physical Therapy & Rehabilitation Science
Comparative Effect of Commercially Available Custom Dynamic Orthoses
US DOD  •  4 years

Other Awards

Ferhaan Ahmad  •  Internal Medicine
MyoKardia, Inc.

Carryn Anderson  •  Radiation Oncology
Superoxide Dismutase Mimetic GC4419 to Reduce Severe Oral Mucositis
Galera Therapeutics, Inc.

David Elliott  •  Internal Medicine
Study in LHA-DQ2.5+ Adults with Celiac Disease to Assess the Effect of Nexvax 2 on Symptoms after Masked Gluten Food Challenge
ImmusanT, Inc.

Muhammad Furqan  •  Internal Medicine
CMP-001 in Combination with Atezolizumab with and without Radiation Therapy in Subjects with Advanced Non-Small Cell Lung Cancer
Checkmake Pharmaceuticals

Delwyn Miller  •  Psychiatry
University of California, San Diego

Michael O'Donnell  •  Urology
Modern Immunotherapy in BCG-Relapsing Urothelial Carcinoma of the Bladder
Hoosier Cancer Research Network, Inc.

Antonio Sanchez  •  Internal Medicine
Rifaximin Soluble Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy
Salix Pharmaceuticals, Inc.

Margarida Silverman  •  Internal Medicine
Ruxolitinib vs. best available therapy in patients with corticosteroid-refractory chronic graft vs host disease after allogenic stem cell transplantation
Incyte Corporation

Lucy Wibbenmeyer  •  Surgery
Efficacy and safety of NexoBrid compared to Standard of Care treatment
MediWound, Inc.



New Federal Awards

Joe Cullen & Doug Spitz  •  Surgery & Rad Onc
Exploiting Redox Metabolism Using Pharmacological Ascorbate for Cancer Therapy 
NIH P01  •  5 years

Joseph Buckwalter  •  Orthopedics & Rehabilitation
Translating Metabolic Responses to Mechanical Insult into Early Interventions to Prevent PTOA
US Department of Defense

Paul McCray  •  Pediatrics
CRISPR Ribonucleoproteins to Airway Epithelia Using Novel Amphiphilic Peptides  
NIH UG3  •  3 years

Hai-Hai Xue  •  Microbiology
Ezh2 regulates follicular helper T cell differentiation 
NIH R01  •  5 years

Chris Adams  •  Internal Medicine
Novel signaling pathways underlying skeletal muscle atrophy
NIH R01  •  5 years

David Weiss  •  Microbiology
Peptidoglycan binding protein specificity and bacterial cell division 
NIH R01  •  4 years

Georgina Aldridge  •  Neurology
Cortical Mechanisms in Lewy Body Dementia 
NIH K08  •  5 years

Mitchell Coleman  •  Radiation Oncology
Do Changes in Thiol Metabolism Mediate Osteoarthritis Progression? 
NIH R00  •  3 years

Peg Nopoulos  •  Psychiatry
Transfusion of Prematurity Early School Age Follow-up (TOP 5) CCC  
NIH UG3  •  1 year

Jeffrey Segar  •  Pediatrics
Fenoldopam to prevent renal dysfunction in indomethacin treated preterm infants  
NIH R21  •  2 years

Sharon Idiga  •  Pharmacology
Endocrine Circuit Regulating Sugar Satiety 
NIH F31  •  2 years

Alexander Greiner  •  Internal Medicine
MSX1 in Cardiac Fibrosis and Sudden Death  
NIH F30  •  4 years

Competitive Renewals

David Stoltz  •  Internal Mediciner
Origins of Cystic Fibrosis Airway Disease  
NIH P01  •  5 years

Rob Cornell  •  Anatomy & Cell Biology
Dissecting the transcriptional network governing differentiation of periderm
NIH R56  •  1 year

Todd Washington  •  Biochemistry
Mechanisms of Damaged DNA Replication in Eukaryotes 
NIH R01  •  4 years

Clinical Trial Support

Steven Polyak  •  Internal Medicine
Upadacitinib (ABT-494) in Subjects with Crohn's Disease
AbbVie Inc.

Randy Loftus  •  Anesthesia
Reducing Perioperative S. aureus Transmission
Anesthesia Patient Safety Foundation

Mo Milhem  •  Internal Medicine
DSP-7888 Dosing in Combination with Immune Checkpoint Inhibitors in Adult Subjects with Advanced Solid Tumors
INC Research, LLC

Steven Lentz  •  Internal Medicine
Pathfinder 8
Novo Nordisk, Inc.

Kirill Nourski  •  Neurosurgery
Mechanisms of anesthetic-induced unconsciousness
University of Wisconsin-Madison


AUGUST 2018 

New Federal Awards

Enrique Leira  •  Neurology
UI Regional Stroke Research Network 
NIH U21  •  5 years

Robert Weiss  •  Internal Medicine
Injury in Calcific Aortic Valve Disease
NIH R01  •  4 years

Stephen Hillis  •  Radiology
Generalized Obuchowski-Rockette Methodology for Analysis of Radiologic Diagnostic Imaging
NIH R01  •  4 years

Michael Anderson  •  Physiology
Genetic modifiers of Cep290-mediated retinal degeneration  
NIH R21  •  2 years

Rudragouda Channappanavar  •  Microbiology
Interferon lambda in host protection during aging 
NIH R21  •  2 years

Ali Jabbari  •  Dermatology
Defining T helper cell associated cytokines and mechanisms in Alopecia Areata   
NIH K08  •  3 years

Competitive Renewals

Rob Cornell  •  Anatomy & Cell Biology
Regulation of the Melanocyte Lineage by the AP2 Transcription Factor Family
NIH R01  •  5 years

Rob Piper  •  Physiology
Ubiquitin-dependent sorting in endosomes and the TGN
NIH R01  •  4 years

Clinical Trial Support

Steven Polyak  •  Internal Medicine
Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Crohn's Disease
AbbVie, Inc

Mark Santillan  •  Obstetrics & Gynecology
Mechanisms of Early and Late Postpartum Hypertension in Human Preeclampsia
American Heart Association

Huy Tran  •  Internal Medicine
Obeticholic Acid in Subjects with Cirrhosis
Intercept Pharmaceuticals, Inc.

Michael Ohl  •  Internal Medicine
Public Health-Partnered Tele-Medical Pre-Exposure Prophylaxis Delivery in a Rural State
Iowa Department of Public Health

Sneha Deepak Phadke  •  Internal Medicine
Alpelisib plus fulvestrant or letrozole in patients with PIK3CA

Muhammad Furqan  •  Internal Medicine
First-Line Therapy in Patients with Metastatic NSCLC
Pharmaceutical Research Associates


JULY 2018 

New Federal Awards

Dan Weeks  •  Biochemistry
Amyloids, aggregates and nucleolar activity in Xenopus development
NIH R01  •  4 years

Frank Faraci  •  Internal Medicine
Central RAAS and Brain Small Vessel Disease
NIH R01  •  5 years

Robert Block  •  Anesthesia
General Anesthesia During Early Childhood and Brain Development 
NIH R01  •  5 years

Wendy Maury  •  Microbiology
Modeling Filovirus Infection of and Trafficking through Skin  
NIH R01  •  4 years

Catherine Musselman  •  Biochemistry
Molecular mechanisms of histone signaling in a chromatin relevant context  
NIH R35  •  5 years

Adam Dupuy  •  Anatomy & Cell Biology
The role germline polymorphisms on ALL susceptibility  
NIH R21  •  2 years

Bradley Erickson  •  Urology
Understanding the Role of Local & Systemic Inflammation in Male Urethral Stricture Disease  
NIH R21  •  2 years

Rebecca Dodd  •  Internal Medicine
Mechanisms of NF1+/- Myeloid Cell Function in MPNSTs
US Department of Defense

Loreen Herwaldt  •  Internal Medicine
SHEPheRD RFTOP 2018 Domain-1-A001
US Dept of HHS 

Laurie Gutmann, Harold Adams, Nandakumar Narayanan, Mike Shy, Katherine Matthews & Peggy Nopoulos  •  Neurology, Pediatrics & Psychiatry
University of Iowa's NeuroNEXT Clinical Research Site   
NIH U24  •  5 years

Competitive Renewals

John Harty  •  Microbiology
Understanding immune regulation in blood-stage malaria
NIH R01  •  4 years

Clinical Trial Support

Mony Fraer  •  Internal Medicine
OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy
Omeros Corporation

Mo Milhem  •  Internal Medicine
UV1 Vaccine in First-Line Malignant Melanoma Patients
Ultimovacs AS